Transdermal on the Net

With a focus on drug delivery and Drug delivery.

AP Pharma
Advanced Polymer Systems Inc. is a leader in polymer-based delivery systems and related technologies with a broad proprietary and intellectual property platform.
Topically delivered steroid products for human use, and adjuvants and custom encapsulation services for vaccines and drugs
Specializing in trans-barrier drug delivery technolgies.
Journal of Drug Targeting
Published by The Gordon and Breach Publishing Group.
Drug Delivery Research Group
Pharmaceutical Sciences Research Institute of Aston University. Drug Delivery Research Group homepage.
CeNeS Pharmaceuticals
CeNeS Pharmaceuticals is focused on developing drugs for CNS disorders and pain control and the development of controlled release drug delivery products.
Watson Pharmaceuticals
Development of innovative pharmaceutical products based on its transdermal, oral transmucosal, oral controlled-release, topical and cell-targeted drug delivery technologies.
MIKA Pharma
Developer and manufacturer of dermal and transdermal application systems for pharmaceuticals on the basis of sprayable liposomes and pre-liposomal solutions.
BioChemics, Inc.
Pharmaceutical company focused on the development of transdermally delivered drugs and patchless, gel-based transdermal drug delivery systems.
CancerWeb: White Paper
Original summaries of selected Cancerlit records, Drug Delivery For Localized Uterine Cervical Disease.
Helix Biopharma Corp.
Focusing on the development of drug and vaccine delivery systems.
Offers biopharmaceutical companies a unique resource for the development of technology and alternative drug delivery systems.
Specializing in an extensive range of proprietary drug delivery technologies. Based in Ireland.
Drug Delivery Division, developing the technology called Electroporation Therapy to deliver life-saving drugs and beneficial genes directly into human cells.
Aston University School of Life & Health Sciences Pharmaceutical Sciences Research Institute
Emphasis is on strategies for the delivery and targeting of polar, unstable and macromolecular therapeutic agents.
Nb of rev= 15